Background illustration for clinical trials search

Paid Clinical Trials Newnan

Discover 1,605 paid clinical trials in Newnan, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,605

Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.

for

Digestive System Neuroendocrine Tumor,

Location: Atlanta GA

Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT07150546

Phase1, Recruiting

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

for

Metastatic Salivary Gland Carcinoma,

Location: Atlanta GA, Nashville TN, Charleston SC, Lexington KY,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05408845

Phase2, Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for

Cutaneous Melanoma, Stage II

Location: Atlanta GA, Savannah GA, Mobile AL, Jacksonville FL,

Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

for

Malignant Digestive System Neoplasm

Location: Atlanta GA

Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT03800693

Phase2, Recruiting

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for

Colorectal Neoplasms

Location: Atlanta GA, Nashville TN, Wytheville VA, Pinehurst NC,

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT05253651

Phase3, Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

for

Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma

Location: Atlanta GA, Knoxville TN, Nashville TN, Charlotte NC,

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT04031677

Phase3, Recruiting

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

for

Tricuspid Regurgitation, Tricuspid Valve Insufficiency,

Location: Atlanta GA, Gainesville FL, Chapel Hill NC, Roanoke VA,

Sponsor: Edwards Lifesciences

Sex: All

Age: 18+

Code: NCT04097145

Recruiting

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

for

Hereditary Leiomyomatosis and Renal Cell Carcinoma,

Location: Atlanta GA, Columbus OH, Bethesda MD, Houston TX

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT04981509

Phase2, Recruiting

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

for

Clostridium Difficile, Clostridium Difficile Infections,

Location: Atlanta GA, Decatur GA, Marietta GA, Athens GA,

Sponsor: Vedanta Biosciences, Inc.

Sex: All

Age: 12+

Code: NCT06237452

Phase3, Recruiting

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

for

Metastatic Urothelial Carcinoma,

Location: Atlanta GA, Miami FL, Dallas TX, New York NY,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06439836

Phase1, Recruiting

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

for

Classic Follicular Lymphoma,

Location: Atlanta GA, Birmingham AL, Augusta GA, Charlotte NC,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06337318

Phase3, Recruiting

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

for

Metastatic Nasopharyngeal Carcinoma,

Location: Atlanta GA, Charleston SC, Effingham IL, Mattoon IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06029270

Phase2, Recruiting

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

for

Advanced Lung Non-Small Cell Carcinoma,

Location: Atlanta GA, Pinehurst NC, Cape Girardeau MO,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03191149

Phase2, Recruiting

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

for

Smoldering Plasma Cell Myeloma

Location: Atlanta GA, Birmingham AL, Seneca SC, Greenville SC,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT03937635

Phase3, Recruiting

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

for

Renal Pelvis and Ureter Urothelial Carcinoma

Location: Atlanta GA, Decatur GA, Lexington KY, Cape Girardeau MO,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04628767

Phase2, Phase3, Recruiting

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

for

Refractory Differentiated Thyroid Gland Carcinoma

Location: Atlanta GA, Nashville TN, Charleston SC, Lexington KY,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT06475989

Phase3, Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

for

Advanced Lung Non-Squamous Non-Small Cell Carcinoma,

Location: Atlanta GA, Columbus MS, Savannah GA, New Albany MS,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04181060

Phase3, Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

for

Metastatic Malignant Neoplasm in the Liver,

Location: Atlanta GA, Decatur GA, Seneca SC, Easley SC,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05040360

Phase2, Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for

Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,

Location: Atlanta GA, Hendersonville NC, Nashville TN,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase2, Recruiting

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

for

Leukemia, Myelomonocytic, Chronic

Location: Atlanta GA, Tampa FL, Houston TX, Rochester MN

Sponsor: Theradex

Sex: All

Age: 18+

Code: NCT07033598

Phase2, Recruiting

Paid Clinical Trials Newnan

Filter results

Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Interested in new trials?

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia